A Phase II Study of AL-37807 to Treat Open-Angle Glaucoma or Ocular Hypertension

Status:
Completed

Trial end date:
1969-12-31

Target enrollment:

Participant gender:

The purpose of this study is to determine whether AL-37807 is safe and effective in treating patients with open-angle glaucoma or ocular hypertension

Phase 2

Alcon Research